Clinical Trials Directory

Trials / Completed

CompletedNCT01910493

Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique

Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique: A Randomized Control Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,352 (actual)
Sponsor
Absolute Return for Kids · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Mobile phone SMS are increasingly used to promote positive health behaviour with an aim to improve health outcomes. However, robust data on the efficacy of SMS on health seeking behaviour and patient outcomes in resource-limited settings is sparse. The SMSaude study aims to assess whether regular SMS-reminders improve retention on antiretroviral therapy (ART) and prevention of mother to child transmission of HIV (PMTCT) programmes in Mozambique.

Detailed description

SMSaúde is a multisite randomised clinical trial of HIV-infected adults on ART and HIV-infected pregnant women in six clinics in Maputo Province, Mozambique. Eligibility criteria include: currently residing in the province; no plans to move for 12+ months; have own cell-phone; literate; 8-28 weeks pregnant (PMTCT cohort); on first line ART and on ART for \>15 days (ART cohort). Patients were interviewed for eligibility, and then randomized (1:1). SMS reminders are sent to the intervention group using software that picks up the patient's next appointment from the electronic patient database. Primary outcomes tested were improved retention in ART care and uptake of all PMTCT services.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSMS remindersIntervention participants only will be sent text messages to their phones. The content of text messages will have a maximum of 160 characters and not mention HIV and will state the dates for the forthcoming consultations, visits to the pharmacy, lab results, time to take medication and reminders for patients who miss appointments.

Timeline

Start date
2011-11-01
Primary completion
2013-05-01
Completion
2013-06-01
First posted
2013-07-29
Last updated
2013-07-29

Locations

1 site across 1 country: Mozambique

Source: ClinicalTrials.gov record NCT01910493. Inclusion in this directory is not an endorsement.